Imunon, Inc. is a clinical-stage biotechnology company. It is focused on advancing a portfolio of treatments that harness the body’s natural mechanisms across an array of human diseases. It has two platform technologies: TheraPlas platform for the de... Read more
CNBC
Yahoo
SeekingAlpha
MarketWatch
Access detailed stock analysis from LSEG including analyst price target estimates.